Drug intelligence / Profile preview

Quell

Development stage: Unknown
Lead developer: NeuroMetrix
Administration: Transdermal

Overview

Quell is a wearable neuromodulation device designed to help reduce symptoms of fibromyalgia and chronic pain. It uses transcutaneous electrical nerve stimulation (TENS) technology to deliver precise, high-power nerve stimulation via a band worn on the upper calf. The device is non-invasive, drug-free, and can be used during sleep. It features position and motion sensing for automatic adjustment of stimulation intensity and supports Bluetooth connectivity for integration with mobile apps and cloud-based health monitoring[6][9].

Brand names: QuellQuell Fibromyalgia

Beyond the preview

Go deeper on Quell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quell.

Explore the full profile